PSMA PET/CT scan to guide care after prostate cancer treatment
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You live in Alberta, the Northwest Territories, or Yukon
- You had prostate cancer treatment such as surgery or radiation, and your PSA is high or rising
- One of the following applies: PSA ≥ 0.2 after prostate surgery, OR PSA ≥ 2 with rising levels after other treatments, OR PSA doubling time under 9 months
- You can provide recent cancer details (like biopsy results or risk features such as Gleason score, PSA level, or tumor stage)
- You can complete the scan: you can lie flat for 30 minutes and have an IV line for the tracer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides access to a new type of PET/CT scan called 18F-PSMA-1007, which uses a radioactive tracer to find prostate cancer cells that may have spread in the body. The scan may help your doctor plan your treatment more accurately.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This study uses a special scan called PET/MR with a prostate-focused tracer to help doctors choose the best next treatment for prostate cancer. It may be most helpful if you are planning major treatment or if your cancer has come back after prior treatment.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.